| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/09/2006 | US20060052445 Diarylsulfones as 5-HT2A antagonists |
| 03/09/2006 | US20060052421 Conjugation agent |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | US20060052366 Pyridine derivatives as fungicidal compounds |
| 03/09/2006 | US20060052315 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/09/2006 | US20060052247 Novel herbicides |
| 03/09/2006 | US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 03/09/2006 | DE4344422B4 Pyri(mi)din-Derivate und flüssigkristallines Medium Pyri (mi) dine derivatives and liquid crystalline medium |
| 03/09/2006 | CA2576973A1 Benzamide compounds |
| 03/09/2006 | CA2571989A1 Modulators of nuclear receptors |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632236A1 Inhibitors of the anandamide transporter |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |
| 03/08/2006 | EP1631549A2 3-[2-(3-amino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 03/08/2006 | EP1631548A2 Inhibitors of akt activity |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1631285A1 Therapeutic agents useful for treating pain |
| 03/08/2006 | EP1631143A1 Hydrazone derivatives for combatting harmful insects and arachnids |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1387839B1 Process for the production of quinazolines |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1198454B1 Mutilin derivatives and their use as antibacterials |
| 03/08/2006 | EP0948327B1 Antidiabetic agents |
| 03/08/2006 | EP0938476B1 Process for substituted pyridines |
| 03/08/2006 | EP0771190B1 Lock and key micelles |
| 03/08/2006 | CN1745078A Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 03/08/2006 | CN1745071A Novel ethylenediamine derivatives |
| 03/08/2006 | CN1745067A Biphenylcarboxamide compound |
| 03/08/2006 | CN1745064A Pyridines for treating injured mammalian nerve tissue |
| 03/08/2006 | CN1745061A Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it |
| 03/08/2006 | CN1744900A Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide |
| 03/08/2006 | CN1743313A One-step reaction method for preparing 4-nitropyridine-nitrogen oxide and halogenated-4-nitropyridine-nitrogen oxide |
| 03/08/2006 | CN1743312A Fused-polycyclic compounds |
| 03/08/2006 | CN1743302A Arylpiperazines having 5-hydroxyl-typtamine activity |
| 03/08/2006 | CN1244562C Process of synthesis of a tricyclic ketone intermediate |
| 03/08/2006 | CN1244560C Method for preparing 4-haloalkyl nicotine nitriles |
| 03/08/2006 | CN1244559C Pyridine salt derivative as strong two-photon absorbing material and its preparation process |
| 03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7009058 Method for preparing pyridine-2,3-dicarboxylic acid esters |
| 03/07/2006 | US7009051 4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/07/2006 | US7008636 such as 5'-Octadecyloxy-[1,1';3',1'']terphenyl-2'-yloxy acetic acid for inhibiting Protien-Tyrosine Phosphatases(PTPases) from rat liver microsomes in vitro; for treatment of associated obesity, glucose intolerance, diabetes mellitus, hypertension |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | WO2006021848A1 Anti-inflammatory agents |
| 03/02/2006 | WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 03/02/2006 | WO2006021805A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | WO2006021565A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | WO2006021390A1 Method for the production of tricyanomethanides of organic cations |
| 03/02/2006 | WO2006021302A1 Method for producing high-purity quaternary ammonium compounds |
| 03/02/2006 | WO2005120477A3 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators |
| 03/02/2006 | WO2005115984A3 Large conductance calcium-activitated k channel opener |
| 03/02/2006 | WO2005030766A8 Phenyl - carboxamide compounds useful for treating pain |
| 03/02/2006 | WO2004110364A3 Thiotungstate analogues and uses thereof |
| 03/02/2006 | US20060047172 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight |
| 03/02/2006 | US20060047125 crystal structure |
| 03/02/2006 | US20060047124 Reducing with hydrogen using 3-substituted-2,5,6-trifluoropyridine as a starting material for preparing 2-aminopyridine derivatives |
| 03/02/2006 | US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents |
| 03/02/2006 | US20060046991 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 03/02/2006 | US20060046095 Cyclometalated transition metal complex and organic electroluminescent device using the same |
| 03/02/2006 | CA2578283A1 Heterocyclic compounds and methods of use |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2578115A1 O-aminophenol derivatives and dyes containing these compounds |
| 03/02/2006 | CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 03/02/2006 | CA2577837A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | CA2576325A1 Optically active phthalamide derivative, agricultural or horticultural insecticide, and method of using the same |
| 03/01/2006 | EP1629063A1 Organic electroluminescent devices and metal complex compounds |
| 03/01/2006 | EP1628998A2 A tag for purification of peptides |
| 03/01/2006 | EP1628985A2 Chiral ligands and their transition metal complexes |
| 03/01/2006 | CN1741997A Process for conversion of cyanopyridines tonicotinamides and catalyst therefor, process for preparing said catalyst |
| 03/01/2006 | CN1741996A Carboxamide derivatives and their use as factor XA inhibitors |
| 03/01/2006 | CN1741992A 大麻素受体配体 Cannabinoid receptor ligands |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 03/01/2006 | CN1740159A Nicotinic acid preparing process |
| 03/01/2006 | CN1740158A Synthesis process of Tilofiban hydrochloride intermediate |
| 03/01/2006 | CN1243751C Piperidine compounds as anti-allergic medicine |
| 03/01/2006 | CN1243739C Method for production of 1,3-disubstituted 2-nitroguanidines |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 03/01/2006 | CN1243721C Substituted amino compounds and their use as substances having analgesic effect |
| 02/28/2006 | US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 02/28/2006 | US7005521 Catalytic compositions and methods for asymmetric allylic alkylation |
| 02/28/2006 | US7005520 cyclization of a 3-amidyl-4-amino-pyrazole compound with n-hydroxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzenecarboximidamidine compound; anti-impotency drugs |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | CA2332535C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2006018326A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041145 Process for producing pyridylethylthio compound, modified ion exchanger and process for producing the same, and process for producing bisphenol compound |